Evidence map›Paper›PMID 23405163›Full record

ArticlePloS one2013

Differential phosphorylation of perilipin 1A at the initiation of lipolysis revealed by novel monoclonal antibodies and high content analysis.

Patrick M McDonough, Dominique Maciejewski-Lenoir, Sean M Hartig, Rita A Hanna, Ross Whittaker, Andrew Heisel, James B Nicoll, Benjamin M Buehrer, Kurt Christensen, Maureen G Mancini and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. PasteurizedGut microbes · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Patrick M McDonoughVala Sciences Inc, San Diego, California, United States of America. pmcdonough@valasciences.com
Dominique Maciejewski-Lenoir
Sean M Hartig
Rita A Hanna
Ross Whittaker
Andrew Heisel
James B Nicoll
Benjamin M Buehrer
Kurt Christensen
Maureen G Mancini
Michael A Mancini
Dean P Edwards
Jeffrey H Price
Baylor College of Medicine · USVala Sciences (United States) · USZen Bio (United States) · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTIONU54HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 1998 to 2013
$19.9M
HT Image Assay of Lipid Droplet Formation in Human AdipocytesR44DK074333 · NIDDK · VALA SCIENCES, INC. · PI MCDONOUGH, PATRICK M · 2008 to 2009
$1.5M
Unique Roles of p160 Coactivators during Human AdipogenesisF32DK085970 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HARTIG, SEAN · 2009 to 2010
$102k
NCI NIH HHS P30 CA-125123NCI NIH HHS P30 CA125123NICHD NIH HHS U54 HD-007495NICHD NIH HHS U54 HD007495NIDDK NIH HHS 1F32DK85979.NIDDK NIH HHS 5R44DK074333NIDDK NIH HHS F32 DK085970NIDDK NIH HHS P30 DK056338NIDDK NIH HHS P30 DK-56338NIDDK NIH HHS R44 DK074333
6 · The paper itself

Abstract

Lipolysis in adipocytes is regulated by phosphorylation of lipid droplet-associated proteins, including perilipin 1A and hormone-sensitive lipase (HSL). Perilipin 1A is potentially phosphorylated by cAMP(adenosine 3',5'-cyclic monophosphate)-dependent protein kinase (PKA) on several sites, including conserved C-terminal residues, serine 497 (PKA-site 5) and serine 522 (PKA-site 6). To characterize perilipin 1A phosphorylation, novel monoclonal antibodies were developed, which selectively recognize perilipin 1A phosphorylation at PKA-site 5 and PKA-site 6. Utilizing these novel antibodies, as well as antibodies selectively recognizing HSL phosphorylation at serine 563 or serine 660, we used high content analysis to examine the phosphorylation of perilipin 1A and HSL in adipocytes exposed to lipolytic agents. We found that perilipin PKA-site 5 and HSL-serine 660 were phosphorylated to a similar extent in response to forskolin (FSK) and L-γ-melanocyte stimulating hormone (L-γ-MSH). In contrast, perilipin PKA-site 6 and HSL-serine 563 were phosphorylated more slowly and L-γ-MSH was a stronger agonist for these sites compared to FSK. When a panel of lipolytic agents was tested, including multiple concentrations of isoproterenol, FSK, and L-γ-MSH, the pattern of results was virtually identical for perilipin PKA-site 5 and HSL-serine 660, whereas a distinct pattern was observed for perilipin PKA-site 6 and HSL-serine 563. Notably, perilipin PKA-site 5 and HSL-serine 660 feature two arginine residues upstream from the phospho-acceptor site, which confers high affinity for PKA, whereas perilipin PKA-site 6 and HSL-serine 563 feature only a single arginine. Thus, we suggest perilipin 1A and HSL are differentially phosphorylated in a similar manner at the initiation of lipolysis and arginine residues near the target serines may influence this process.

Indexed as

3T3-L1 CellsAdipocytesAdultAnimalsAntibodies, MonoclonalAntibody SpecificityArginineBlotting, WesternCarrier ProteinsCyclic AMP-Dependent Protein KinasesEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryFluorescent Antibody TechniqueHeLa CellsHumansAntibodies, MonoclonalArginineCarrier ProteinsCyclic AMP-Dependent Protein KinasesPerilipin-1PhosphoproteinsRNA, Small InterferingSerine

Identifiers

PMID23405163
PMCPMC3566132
OpenAlexW2046137181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.